TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients

Stage IV Melanoma Patients With Unresectable Liver Metastases Clinical Trial

Official title: TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients

Status Recruiting

Clinical Trial Summary

The Aim is to evaluate safety and efficacy of TACE with doxorubicin-loaded DC beads in melanoma patients with liver metastasis. This is a pilot study with the aim of recruiting 20 patients, this is a feasibility study. the patients profile is patients with stage IV Melanoma with liver metastases.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Liver Neoplasms
• Melanoma
• Neoplasm Metastasis
• Stage IV Melanoma Patients With Unresectable Liver Metastases

• NCT number: NCT01409733
• Study type: Interventional
• Source: Heidelberg University
• Contact: Philippe Pereira, MD
• Phone: +49 71 31 49-38 01
• Email: philippe.pereira@slk-kliniken.de
• Status: Recruiting
• Phase: Phase 1/Phase 2
• Start date: June 2010
• Completion date: December 2012